(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc

CAT:
804-HY-163225
Size:
Inquire

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc - image 1

(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc

  • UNSPSC Description:

    (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc is a conjugate of E3 ligase ligand and linker, consisting of Thalidomide (HY-14658) and the corresponding Linker. (S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc can serve as a Cereblon ligand to recruit CRBN protein and serve as a key intermediate for the synthesis of complete PROTAC molecules.
  • Target Antigen:

    Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis;Autophagy;PROTAC
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    cancer
  • Assay Protocol:

    https://www.medchemexpress.com/e3-ligase-ligand-linker-conjugate-78.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C1NC(CC[C@@H]1N2C(C3=C(C=CC(N4CCN(CC4)C[C@H]5CC[C@@H](CC5)NC(OC(C)(C)C)=O)=C3)C2=O)=O)=O
  • Molecular Weight:

    553.65
  • References & Citations:

    [1]Fischer ES, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014 Aug 7;512(7512):49-53.|[2]Sun X, et al. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. Med Sci Monit. 2018 May 15;24:3193-3203.|[3]Bian C, et al. Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-β/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radic Biol Med. 2018 Dec;129:446-453.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported